Skip to content

Investigation of the efficacy and safety of laparoscopic cervico-isthmus cerclage in cases that are difficult to treat with transvaginal cervical cerclage

Investigation of the efficacy and safety of laparoscopic cervico-isthmus cerclage in cases that are difficult to treat with transvaginal cervical cerclage - Safe and Efficient Trial of Laparoscopic transabdominal Cervico-Isthmic Cerclage (SET-LCIC)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035109
Enrollment
30
Registered
2018-12-03
Start date
2017-11-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical incompetence

Interventions

Laparoscopic Cervico-isthmic Cerclage: LCIC

Sponsors

The department of obstetrics and gynecology, Showa University Northern Yokohama Hospital
Lead Sponsor
Department of Obstetrics and Gynecology Showa University School of Medicine
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1)A pregnant patient with cervical incompetency. The clinical conditions listed below are the specific targets identified: 1.Patients with loss of the uterine cervix after uterine conization 2.Women with uterine cervix cleavage 3.Women with vaginal deformation due to laceration of the cervix 4.Women who had a premature delivery despite having undergone transvaginal cervical cerclage in the past 5.Women with cervical incompetency occurring in the first and/or second trimesters of pregnancy 6.Women with a history of premature delivery at a gestational age of <34 weeks or shortening of the cervical length (<25 mm) confirmed on transvaginal ultrasonography in the early pregnancy period. 7.A patient judged by the medical officer responsible for performing the treatment and the attending physician as requiring such treatment 2)A patient who is at least 16 years old but <55 years old at the time of giving her consent. 3)A patient who personally gives her written informed consent to participate in this study. In the event that the age of the patient is <20 years, a written informed consent must be obtained from the legally acceptable representative of the patient. 4)A patient who is eligible for this study is confirmed by several specialists and will be selected carefully once the safety of the patient is ensured.

Exclusion criteria

Exclusion criteria: 1) A pregnant woman for whom LCIC is judged to be impossible to perform because of intense intra-abdominal adhesion 2) A pregnant woman with intrauterine fetal death prior to LCIC 3) A pregnant woman judged to be in a state with a high possibility of the fetus aborting before LCIC 4) A pregnant woman with a coexisting malignant tumor 5) A pregnant woman judged by the principal investigator as not eligible to participate in the study

Design outcomes

Primary

MeasureTime frame
Prolonging pregnancy: especially prolonging pregnancy after 34 weeks of gestational age

Secondary

MeasureTime frame
Neonatal prognosis and neonatal information. For example, height, weight, Apgar score etc.

Countries

Japan

Contacts

Public ContactKohei Seo

Showa University Northern Yokohama Hospital The department of obstetrics and gynecology

seo@med.showa-u.ac.jp045-949-7000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026